These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 1651784

  • 1. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus.
    Gustafsson B, Jondal M, Sundqvist VA.
    Hum Antibodies Hybridomas; 1991 Jan; 2(1):26-32. PubMed ID: 1651784
    [Abstract] [Full Text] [Related]

  • 2. Antibody production of a human EBV-transformed B cell line and its heterohybridoma and trioma cell line descendants in different culture systems.
    Gustafsson B, Hinkula J.
    Hum Antibodies Hybridomas; 1994 Jan; 5(3-4):98-104. PubMed ID: 7756584
    [Abstract] [Full Text] [Related]

  • 3. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H, Hirata Y, Sugawara I, Fukuda A, Yoshida TO.
    Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
    [Abstract] [Full Text] [Related]

  • 4. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line.
    Jahn S, Walper A, Grunow R, Heym S, Volk HD, von Baehr R.
    Allerg Immunol (Leipz); 1990 Dec; 36(4):359-65. PubMed ID: 1965878
    [Abstract] [Full Text] [Related]

  • 5. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H, Xu ZL, Wang Y, Yang L, Feng O, Li Y, Wang YM, Zhang GG.
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [Abstract] [Full Text] [Related]

  • 6. Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes.
    Kalantarov GF, Rudchenko SA, Lobel L, Trakht I.
    Hum Antibodies; 2002 Jan; 11(3):85-96. PubMed ID: 12454369
    [Abstract] [Full Text] [Related]

  • 7. Increased human hybridoma formation by electrofusion of human B cells with heteromyeloma SPAM-8 cells.
    Panova I, Gustafsson B.
    Hybridoma; 1995 Jun; 14(3):265-9. PubMed ID: 7590790
    [Abstract] [Full Text] [Related]

  • 8. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
    Garzelli C, Puglisi C, Falcone G.
    Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
    [Abstract] [Full Text] [Related]

  • 9. Extensive loss of human DNA accompanies loss of antibody production in heteromyeloma hybridoma cells.
    Koropatnick J, Pearson J, Harris JF.
    Mol Biol Med; 1988 Apr; 5(2):69-83. PubMed ID: 3260988
    [Abstract] [Full Text] [Related]

  • 10. A human myeloma cell line suitable for the generation of human monoclonal antibodies.
    Karpas A, Dremucheva A, Czepulkowski BH.
    Proc Natl Acad Sci U S A; 2001 Feb 13; 98(4):1799-804. PubMed ID: 11172031
    [Abstract] [Full Text] [Related]

  • 11. Human monoclonal antibodies to cytomegalovirus recognize viral epitopes on the surface of virus-infected cells.
    Larose Y, Tackaberry ES, Brodeur BR.
    Hum Antibodies Hybridomas; 1991 Apr 13; 2(2):67-73. PubMed ID: 1714785
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A human hybrid myeloma for production of human monoclonal antibodies.
    Kozbor D, Tripputi P, Roder JC, Croce CM.
    J Immunol; 1984 Dec 13; 133(6):3001-5. PubMed ID: 6092464
    [Abstract] [Full Text] [Related]

  • 14. Incorporation of T cell counterparts in the fusion partners for generation of human monoclonal antibodies from Staphylococcus aureus stimulated B lymphocytes.
    Gore MM, Singhania SS, Basu A, Banerjee K.
    Hum Antibodies; 1997 Dec 13; 8(1):26-32. PubMed ID: 9265502
    [Abstract] [Full Text] [Related]

  • 15. Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell lines.
    Hilfenhaus J, Kanzy EJ, Köhler R, Willems WR.
    Behring Inst Mitt; 1986 Jun 13; (80):31-41. PubMed ID: 3019293
    [Abstract] [Full Text] [Related]

  • 16. Development of specific human mab's by a small scale electrofusion technique: the influence of some physical and chemical factors on hybridoma yield of human peripheral blood lymphocytes XCB-F7 fusions.
    Glaser RW, Jahn S, Grunow R.
    Allerg Immunol (Leipz); 1989 Jun 13; 35(2):123-32. PubMed ID: 2788981
    [Abstract] [Full Text] [Related]

  • 17. A human hybrid hybridoma.
    Tiebout RF, van Boxtel-Oosterhof F, Stricker EA, Zeijlemaker WP.
    J Immunol; 1987 Nov 15; 139(10):3402-5. PubMed ID: 3119707
    [Abstract] [Full Text] [Related]

  • 18. Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies.
    Zanella I, Verardi R, Negrini R, Osio L, Albertini A, Ghielmi S.
    Year Immunol; 1993 Nov 15; 7():213-9. PubMed ID: 8396821
    [No Abstract] [Full Text] [Related]

  • 19. Human monoclonal antibodies recognize early and late viral proteins of human cytomegalovirus.
    Alexander H, Harpprecht J, Podzuweit HG, Rautenberg P, Müller-Ruchholtz W.
    Hum Antibodies Hybridomas; 1994 Nov 15; 5(1-2):81-90. PubMed ID: 7858186
    [Abstract] [Full Text] [Related]

  • 20. [Human monoclonal antibodies with human-mouse hybridomas].
    Naoe T, Kato K, Shiku H, Yamada K.
    Gan To Kagaku Ryoho; 1983 Dec 15; 10(12):2575-81. PubMed ID: 6606396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.